Vimarsana
Biggest News Aggregation in the World

Urs Rohner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Urs Rohner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Urs Rohner Today - Breaking & Trending Today

GSK plc (LON:GSK) Receives Average Recommendation of "Hold" from Analysts - Vimarsana News

GSK plc (LON:GSK) Receives Average Recommendation of "Hold" from Analysts

GSK plc (LON:GSK – Get Free Report) has received an average rating of “Hold” from the seven analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The average […]

GSK (LON:GSK) Price Target Increased to GBX 1,660 by Analysts at JPMorgan Chase & Co. - Vimarsana News

GSK (LON:GSK) Price Target Increased to GBX 1,660 by Analysts at JPMorgan Chase & Co.

GSK (LON:GSK – Free Report) had its target price increased by JPMorgan Chase & Co. from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. They currently have an underweight rating on the stock. A number of other research firms have also recently weighed […]

JPMorgan Chase & Co. Increases GSK (LON:GSK) Price Target to GBX 1,660 - Vimarsana News

JPMorgan Chase & Co. Increases GSK (LON:GSK) Price Target to GBX 1,660

GSK (LON:GSK – Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) in a research note issued to investors on Thursday, MarketBeat.com reports. The firm currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests […]

GSK (LON:GSK) Receives Buy Rating from Shore Capital - Vimarsana News

GSK (LON:GSK) Receives Buy Rating from Shore Capital

Shore Capital reissued their buy rating on shares of GSK (LON:GSK – Free Report) in a research report released on Wednesday morning, MarketBeat reports. Several other analysts have also recently weighed in on the company. Barclays reaffirmed an equal weight rating and set a GBX 1,725 ($21.67) price objective on shares of GSK in a […]

Source: wkrb13.com
GSK plc (LON:GSK) Declares GBX 15 Dividend - Vimarsana News

GSK plc (LON:GSK) Declares GBX 15 Dividend

GSK plc (LON:GSK – Get Free Report) announced a dividend on Wednesday, May 1st, Upcoming.Co.Uk reports. Investors of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share on Thursday, July 11th. This represents a yield of 0.9%. The ex-dividend date of this dividend is Thursday, May 16th. The […]